Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros










Intervalo de año de publicación
1.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 66(3): 223-226, May-Jun 2022. ilus, tab
Artículo en Español | IBECS | ID: ibc-204981

RESUMEN

Introducción: Las fracturas de ramas pélvicas son una entidad frecuente en ancianos que habitualmente se trata de manera conservadora. La hemorragia intrapélvica es una complicación poco frecuente que puede llegar a comprometer la vida del paciente.El objetivo del estudio es determinar la incidencia y los posibles factores de riesgo de sangrado masivo en fracturas de ramas pélvicas por traumatismos de baja energía en pacientes mayores de 65 años. Caso clínico: Estudio observacional de 142 pacientes mayores de 65 años diagnosticados de fractura de ramas pélvicas. Analizamos edad, sexo, localización anatómica según Nakatani, hemoglobina al ingreso, necesidad de ingreso hospitalario, pruebas complementarias, complicaciones y estancia hospitalaria media. Resultados: Todas aquellas fracturas de ramas ilio e isquiopubianas complicadas con sangrado (4 pacientes) se encontraban en el área I de Nakatani, en íntima relación con la arteria obturatriz, arteria pudenda interna y la temida Corona Mortis. Todos los pacientes fueron sometidos a embolización supraselectiva para control hemorrágico. Discusión: Un 2,8% de los pacientes con fracturas de ramas pélvicas pueden sufrir una complicación hemorrágica que comprometa su vida. Establecer posibles factores de riesgo como la toma de medicación antiagregante/anticoagulante o la localización anatómica puede ayudarnos a identificar a estos pacientes y llevar a cabo una vigilancia más estrecha.(AU)


Introduction: Pelvic branch fractures are a common feature in old people which are usually treated conservatively. Massive hemorrhage is a strange complication that can compromise the patient's life.The objective of this study is to determine the incidence and possible risk factors of massive arterial injury in fractures of pelvic branches due to low energy trauma in patients over 65 years old.Clinical case: Observational study of 142 patients diagnosed with pelvic branch fracture, We analyzed the age, sex, anatomical location, hemoglobin, need for hospital admission, complementary diagnostic test, complications and hospital stay. Results: All those ilioisquiopubial fractures complicated with massive bleeding (4 patients) were located in the Nakatani area I in close relationship with the obturator artery, internal pudendal artery and the Corona Mortis. All patients needed supraselective embolization for hemorrhagic control. Three of the patients were taking anticoagulants. Discussion: The 2,8% of patients with pelvic branch fractures may suffer a hemorrhagic complication. Be able to establish possible risk factors such a medication or anatomical location can help us identify these patients and carry out closer surveillance.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Anciano , Hemodinámica , Pelvis/lesiones , Pelvis/cirugía , Incidencia , Hemorragia , Heridas y Lesiones , Estudios Retrospectivos , Ortopedia , Traumatología , Estudios Prospectivos
2.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 66(3): T223-T226, May-Jun 2022. ilus, tab
Artículo en Inglés | IBECS | ID: ibc-204982

RESUMEN

Introduction: Pelvic branch fractures are a common feature in old people which are usually treated conservatively. Massive hemorrhage is a strange complication that can compromise the patient's life.The objective of this study is to determine the incidence and possible risk factors of massive arterial injury in fractures of pelvic branches due to low energy trauma in patients over 65 years old.Clinical case: Observational study of 142 patients diagnosed with pelvic branch fracture, We analyzed the age, sex, anatomical location, hemoglobin, need for hospital admission, complementary diagnostic test, complications and hospital stay. Results: All those ilioisquiopubial fractures complicated with massive bleeding (4 patients) were located in the Nakatani area I in close relationship with the obturator artery, internal pudendal artery and the Corona Mortis. All patients needed supraselective embolization for hemorrhagic control. Three of the patients were taking anticoagulants. Discussion: The 2,8% of patients with pelvic branch fractures may suffer a hemorrhagic complication. Be able to establish possible risk factors such a medication or anatomical location can help us identify these patients and carry out closer surveillance.(AU)


Introducción: Las fracturas de ramas pélvicas son una entidad frecuente en ancianos que habitualmente se trata de manera conservadora. La hemorragia intrapélvica es una complicación poco frecuente que puede llegar a comprometer la vida del paciente.El objetivo del estudio es determinar la incidencia y los posibles factores de riesgo de sangrado masivo en fracturas de ramas pélvicas por traumatismos de baja energía en pacientes mayores de 65 años. Caso clínico: Estudio observacional de 142 pacientes mayores de 65 años diagnosticados de fractura de ramas pélvicas. Analizamos edad, sexo, localización anatómica según Nakatani, hemoglobina al ingreso, necesidad de ingreso hospitalario, pruebas complementarias, complicaciones y estancia hospitalaria media. Resultados: Todas aquellas fracturas de ramas ilio e isquiopubianas complicadas con sangrado (4 pacientes) se encontraban en el área I de Nakatani, en íntima relación con la arteria obturatriz, arteria pudenda interna y la temida Corona Mortis. Todos los pacientes fueron sometidos a embolización supraselectiva para control hemorrágico. Discusión: Un 2,8% de los pacientes con fracturas de ramas pélvicas pueden sufrir una complicación hemorrágica que comprometa su vida. Establecer posibles factores de riesgo como la toma de medicación antiagregante/anticoagulante o la localización anatómica puede ayudarnos a identificar a estos pacientes y llevar a cabo una vigilancia más estrecha.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Anciano , Hemodinámica , Pelvis/lesiones , Pelvis/cirugía , Incidencia , Hemorragia , Heridas y Lesiones , Estudios Retrospectivos , Ortopedia , Traumatología , Estudios Prospectivos
3.
Rev Esp Cir Ortop Traumatol ; 66(3): 223-226, 2022.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34148809

RESUMEN

INTRODUCTION: Pelvic branch fractures are a common feature in old people which are usually treated conservatively. Massive hemorrhage is a strange complication that can compromise the patient's life. The objective of this study is to determine the incidence and possible risk factors of massive arterial injury in fractures of pelvic branches due to low energy trauma in patients over 65 years old. CLINICAL CASE: Observational study of 142 patients diagnosed with pelvic branch fracture, We analyzed the age, sex, anatomical location, hemoglobin, need for hospital admission, complementary diagnostic test, complications and hospital stay. RESULTS: All those ilioisquiopubial fractures complicated with massive bleeding (4 patients) were located in the Nakatani area I in close relationship with the obturator artery, internal pudendal artery and the Corona Mortis. All patients needed supraselective embolization for hemorrhagic control. Three of the patients were taking anticoagulants. DISCUSSION: The 2,8% of patients with pelvic branch fractures may suffer a hemorrhagic complication. Be able to establish possible risk factors such a medication or anatomical location can help us identify these patients and carry out closer surveillance.

4.
Radiologia ; 56 Suppl 1: 21-8, 2014 Jun.
Artículo en Español | MEDLINE | ID: mdl-25304299

RESUMEN

Gadolinium-based contrast agents are increasingly being used in magnetic resonance imaging. These agents can improve the contrast in images and provide information about function and metabolism, increasing both sensitivity and specificity. We describe the gadolinium-based contrast agents that have been approved for clinical use, detailing their main characteristics based on their chemical structure, stability, and safety. In general terms, these compounds are safe. Nevertheless, adverse reactions, the possibility of nephrotoxicity from these compounds, and the possibility of developing nephrogenic systemic fibrosis will be covered in this article. Lastly, the article will discuss the current guidelines, recommendations, and contraindications for their clinical use, including the management of pregnant and breast-feeding patients.


Asunto(s)
Medios de Contraste , Gadolinio , Imagen por Resonancia Magnética , Medios de Contraste/efectos adversos , Humanos , Enfermedades Renales/inducido químicamente , Enfermedades Renales/prevención & control , Imagen por Resonancia Magnética/métodos , Dermopatía Fibrosante Nefrogénica/inducido químicamente , Dermopatía Fibrosante Nefrogénica/prevención & control , Factores de Riesgo
5.
Radiología (Madr., Ed. impr.) ; 56(supl.1): 21-28, jun. 2014. tab
Artículo en Español | IBECS | ID: ibc-141496

RESUMEN

Los medios de contraste basados en gadolinio son cada vez más utilizados en estudios de resonancia magnética. Son capaces de mejorar el contraste en las imágenes y aportar información sobre la función y el metabolismo, aumentando la sensibilidad así como la especificidad diagnóstica. Se describen los diferentes medios de contraste basados en gadolinio aprobados para uso clínico actualmente, sus características principales en base a su estructura química, estabilidad y seguridad. En términos generales son compuestos seguros. No obstante, las reacciones adversas producidas, la posible nefrotoxicidad inducida por estos compuestos, así como la posibilidad de desarrollar fibrosis sistémica nefrogénica serán temas tratados en la presente publicación. Por último, se mencionarán las actuales guías, recomendaciones y contraindicaciones en cuanto a su utilización en el ámbito clínico, incluyendo el manejo en pacientes gestantes y en la lactancia (AU)


Gadolinium-based contrast agents are increasingly being used in magnetic resonance imaging. These agents can improve the contrast in images and provide information about function and metabolism, increasing both sensitivity and specificity. We describe the gadolinium-based contrast agents that have been approved for clinical use, detailing their main characteristics based on their chemical structure, stability, and safety. In general terms, these compounds are safe. Nevertheless, adverse reactions, the possibility of nephrotoxicity from these compounds, and the possibility of developing nephrogenic systemic fibrosis will be covered in this article. Lastly, the article will discuss the current guidelines, recommendations, and contraindications for their clinical use, including the management of pregnant and breast-feeding patients (AU)


Asunto(s)
Adulto , Femenino , Humanos , Lactante , Masculino , Embarazo , Gadolinio/administración & dosificación , Gadolinio/efectos adversos , Gadolinio , Imagen por Resonancia Magnética/tendencias , Medios de Contraste
6.
Rev Clin Esp ; 208(6): 288-94, 2008 Jun.
Artículo en Español | MEDLINE | ID: mdl-18620653

RESUMEN

INTRODUCTION: How to identify monoclonal gammopathies of undeterminated significance (MGUS) at risk for progression has been studied for the last years. AIMS: To study the incidence of MGUS in a region with 300,000 inhabitants and factors which associate with a) monoclonal gammopathy disappearance (transient MGUS) b) evolution to malignant gammopathy. METHODS: Study of 618 MGUS. RESULTS: Incidence: 30/40 new cases a year with increase to 70 cases a years in the latest years of study. Age and gender: 71,4 y (32-100), male/female ratio 1.4. Associated pathology: infection 328, heart diseases 249, rheumatic diseases 211, liver diseases 108, cancer 80, neuropathy 43. Monoclonal proteins: IgG 407, IgM 78, IgD 2, biclonal 16, triclonal 1; no heavy chain 21, light chain Kappa 389. Variables (mean): monoclonal component: 14 g/l, ESR 32,5, bone marrow: 5,9% plasma cells beta2-microglobulin: 2,59 mg/l, albumin: 3,1g/l, bone survey: normal 39,5%. Evolution: transient MGUS 20 cases. Time to disappearance 2,6 months (1,4-4,6). Evolution to malignant gammopathy 24 cases, time to progression 3 years (IC 1,82-4,3). RESULTS: Several factors were associatedç with malignant transformation: heavy chain IgA (p < 0,002), ESR (p < 0,001), age < 70 (p < 0,05), bone marrow percentage of plasma cells (p < 0,002) y ostheoporosis (p < 0,005). A MGUS follow up model is suggested.


Asunto(s)
Transformación Celular Neoplásica , Paraproteinemias/epidemiología , Paraproteinemias/patología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Factores de Riesgo
7.
Rev. clín. esp. (Ed. impr.) ; 208(6): 288-294, jun. 2008. ilus, tab
Artículo en Es | IBECS | ID: ibc-66301

RESUMEN

Introducción. La identificación de las gammapatíasmonoclonales de significado incierto (GMSI) conriesgo elevado de progresión se viene estudiandoen los últimos años.Objetivos. Evaluar la incidencia de las GMSI enun área de 300.000 habitantes y sus factoresasociados: la desaparición del componentemonoclonal (CM), gammapatías transitorias (GMT) ysu evolución a gammapatías malignas (GMM).Métodos. Estudio de 618 GMSI.Resultados. Incidencia: 30-40 casos nuevos/año, conun incremento en los últimos años de hasta 70 casospor año. Edad y sexo: 71,4 años (32-100); relaciónH/F 1,4. Patología asociada: infecciosa 328,cardiológica 249, reumatoidea 211, hepática 108,neoplasia 80 y neuropatía 43. Características del CM:IgG 407, IgA 93, IgM 78, IgD 2, biclonales 16,triclonal 1 y ninguna cadena pesada 21. Cadenasligeras: kappa 389 casos. Variables (media): CM 14 g/l, VSG 32,5 mm, MO porcentaje de células plasmáticas 5,9%, ß2-microglobulina 2,59 mg/l, albúmina 3,1 g/l, serie ósea normal 39,5%. Evolución: GMT 20 casos. Tiempo medio de desaparición 2,6meses (1,4-4,6), GM transformadas a GMM 24 casosTiempo medio de progresión 3 años (IC 1,82-4,3).Resultados. Se identifican como factoresasociados a transformación a GMM: cadena pesadaIgA (p < 0,002), VSG (p < 0,001), edad < 70 años(p < 0,05), porcentaje de CP (p < 0,002) yosteoporosis (p < 0,005). Se propone un modelo de seguimiento de GMSI


Introduction. How to identify monoclonalgammopathies of undeterminated significance(MGUS) at risk for progression has been studied forthe last years. Aims. To study the incidence ofMGUS in a region with 300,000 inhabitants andfactors which associate with a) monoclonalgammopathy disappearance (transient MGUS)b) evolution to malignant gammopathy.Methods. Study of 618 MGUS.Results. Incidence: 30/40 new cases a year withincrease to 70 cases a years in the latest years ofstudy. Age and gender: 71,4 y (32-100),male/female ratio 1.4. Associated pathology:infection 328, heart diseases 249, rheumaticdiseases 211, liver diseases 108, cancer 80,neuropathy 43. Monoclonal proteins: IgG 407,IgM 78, IgD 2, biclonal 16, triclonal 1; no heavychain 21, light chain Kappa 389. Variables (mean):monoclonal component: 14 g/l, ESR 32,5, bonemarrow: 5,9% plasma cells ß2-microglobulin: 2,59 mg/l, albumin: 3,1g/l, bone survey: normal 39,5%. Evolution: transient MGUS 20 cases. Time to disappearance 2,6 months (1,4-4,6). Evolution to malignant gammopathy 24 cases, time to progression 3 years (IC 1,82-4,3).Results. Several factors were associatedçwith malignant transformation: heavy chain IgA (p < 0,002), ESR (p < 0,001), age < 70 (p < 0,05), bone marrow percentage of plasma cells (p < 0,002) y ostheoporosis (p < 0,005). A MGUS follow up model is suggested


Asunto(s)
Humanos , Gammopatía Monoclonal de Relevancia Indeterminada/epidemiología , Paraproteinemias/epidemiología , Factores de Riesgo , Biomarcadores/análisis , Paraproteinemias/fisiopatología , Paraproteínas/aislamiento & purificación , Cadenas Pesadas de Inmunoglobulina/análisis , Osteoporosis/complicaciones
11.
Ann N Y Acad Sci ; 1057: 337-64, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16399905

RESUMEN

The neuroendocrine-reproductive axis designates the functional activity of the hypothalamus-pituitary-gonadal axis. A delicate synchronization of many inputs at these three different levels is vital for normal reproductive function. From the median basal hypothalamus, the median eminence releases gonadotrophin releasing hormone into the portal circulation to reach the anterior pituitary gland. Gonadotrophin releasing hormone is obviously a key hormone for the regulation of the secretion of gonadotrophins LH and FSH.


Asunto(s)
Gónadas/fisiología , Sistema Hipotálamo-Hipofisario/fisiología , Melatonina/metabolismo , Maduración Sexual/fisiología , Envejecimiento/fisiología , Animales , Ritmo Circadiano/fisiología , Retroalimentación Fisiológica , Femenino , Hormona Folículo Estimulante/metabolismo , Hormonas Esteroides Gonadales/metabolismo , Hormona Liberadora de Gonadotropina/metabolismo , Hormona Luteinizante/metabolismo , Masculino , Oocitos/fisiología , Glándula Pineal/fisiología , Hipófisis/fisiología , Prolactina/metabolismo , Ratas , Taquicininas/metabolismo
12.
Neurosci Lett ; 368(3): 243-8, 2004 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-15364404

RESUMEN

The present study examines the influence of maternal pineal gland on the frontal cortex, striatal and testicular concentrations of the tachykinins, neurokinin A (NKA) and substance P (SP). Control, pinealectomized (PIN-X) and PIN-X plus melatonin-treated (PIN-X + MEL) mother rats were prepared. Male offspring rats were studied at 21, 31 and 60 days of age, during the four seasons of the year. In control-offspring tachykinin concentrations in frontal cortex were found at their highest levels in 21-day-old rats with a moderate decrease up to 60 days of age. This developmental pattern was season-dependent, observed only during summer and fall. Maternal PIN-X or PIN-X + MEL resulted in alterations in the offspring, showing during spring and summer significantly higher concentrations (P < 0.01) and during fall significantly lower concentrations of tachykinins in the frontal cortex (P < 0.05, P < 0.01) as compared to control-offspring. The tachykinin concentration in the striatum of control-offspring showed no major modifications throughout the ages studied in the four seasons of the year. With very few exceptions, PIN-X- and PIN-X + MEL did not alter tachykinin concentrations in striatum. Testicular SP concentrations showed a decrease from 21 to 60 days of age. PIN-X or PIN-X + MEL only caused minor and inconsistent modifications in testicular SP levels. In conclusion, our data clearly indicate for the first time that the maternal pineal gland participates in the regulation of the postnatal tachykinin development in some areas of the central nervous system. This effect was more evident in the frontal cortex than in the striatum and testes.


Asunto(s)
Intercambio Materno-Fetal/fisiología , Neuroquinina A/metabolismo , Glándula Pineal/metabolismo , Estaciones del Año , Sustancia P/metabolismo , Animales , Femenino , Lóbulo Frontal/metabolismo , Masculino , Embarazo , Ratas , Ratas Wistar , Testículo/metabolismo
13.
Peptides ; 25(6): 997-1004, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15203247

RESUMEN

The concentrations of neurokinin A (NKA) and substance P (SP), members of tachykinins family, have been studied in all seasons of the year in frontal cortex, striatum and testes of male offspring 21-, 31-, or 60 days old of mother Wistar rats: control, pinealectomized (PIN-X) and pinealectomized + melatonin during pregnancy (PIN- X + MEL) kept under 12h:12h L:D. Control-offspring: in spite of having been kept under constant environmental conditions throughout the year, had marked differences in tachykinin concentrations. The highest tachykinin concentrations in the frontal cortex were found in summer and fall and the lowest in winter and spring. Maternal PIN-X resulted in alterations of this developmental pattern, mainly in PIN-X- and PIN- X + MEL-offspring in which the highest tachykinin concentrations at 21 and 31 days of age were only observed during summer. The alterations were observed up to 60 days of age for both tachykinins, when at this age control-offspring showed similar NKA concentrations. Seasonal variations were still observed in PIN-X- and PIN- X + MEL-offspring. In striatum and testes no mayor modifications throughout the four seasons of the year were found, with very few exceptions. PIN-X did not alter tachykinin concentrations, neither treatment with melatonin did it. In conclusion, our data clearly indicate for the first time that NKA and SP do indeed have seasonal rhythms in frontal cortex and that the maternal pineal gland plays a role in their entrainment already during fetal life.


Asunto(s)
Encéfalo/metabolismo , Neuroquinina A/metabolismo , Glándula Pineal/fisiología , Embarazo/fisiología , Estaciones del Año , Sustancia P/metabolismo , Testículo/metabolismo , Animales , Femenino , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Masculino , Melatonina/farmacología , Neostriado/efectos de los fármacos , Neostriado/metabolismo , Neuroquinina A/fisiología , Glándula Pineal/efectos de los fármacos , Ratas , Ratas Wistar , Sustancia P/fisiología , Testículo/efectos de los fármacos
14.
Arch Soc Esp Oftalmol ; 78(3): 173-6, 2003 Mar.
Artículo en Español | MEDLINE | ID: mdl-12677496

RESUMEN

CASE REPORT: We report the case of a patient who was surgically treated in his right eye because of an uncontrollable glaucoma and a retinal detachment without retinal break. Ultrasound and computed tomography showed diffuse choroidal thickening. During 6 years of follow-up, he developed a major ocular and orbitary invasion and bone marrow infiltration. He was treated by enucleation and chemotherapy with apparent total remission. DISCUSSION: Reactive lymphoid hyperplasia of the uvea consists of a lymphocytic proliferation that primarily involves the uveal tract. This process is regarded as a low malignant condition, but this case of late diagnosis showed a tendency to orbital and systemic extension.


Asunto(s)
Enfermedades de la Coroides/patología , Neoplasias de la Coroides/patología , Glaucoma de Ángulo Abierto/etiología , Linfoma de Células B/patología , Linfoma no Hodgkin/patología , Seudolinfoma/patología , Desprendimiento de Retina/etiología , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Médula Ósea/patología , Enfermedades de la Coroides/cirugía , Neoplasias de la Coroides/tratamiento farmacológico , Neoplasias de la Coroides/cirugía , Ciclofosfamida/administración & dosificación , Progresión de la Enfermedad , Doxorrubicina/administración & dosificación , Enucleación del Ojo , Glaucoma Neovascular/etiología , Glaucoma de Ángulo Abierto/cirugía , Humanos , Cadenas kappa de Inmunoglobulina/sangre , Linfoma de Células B/sangre , Linfoma de Células B/tratamiento farmacológico , Linfoma de Células B/cirugía , Linfoma no Hodgkin/sangre , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/cirugía , Masculino , Invasividad Neoplásica , Neoplasias Orbitales/secundario , Paraproteínas , Prednisona/administración & dosificación , Seudolinfoma/cirugía , Inducción de Remisión , Desprendimiento de Retina/cirugía , Vincristina/administración & dosificación
15.
Arch. Soc. Esp. Oftalmol ; 78(3): 173-176, mar. 2003.
Artículo en Es | IBECS | ID: ibc-22617

RESUMEN

Caso clínico: Se describe el caso de un paciente, intervenido en ojo derecho de glaucoma incontrolable y de desprendimiento de retina sin rotura aparente, que presenta un engrosamiento coroideo en ecografía y en la tomografía computerizada. A lo largo de 6 años desarrolló una gran invasión ocular, orbitaria e infiltración de médula ósea y fue tratado mediante enucleación y quimioterapia con aparente remisión completa. Discusión: La hiperplasia linfoide reactiva de la úvea consiste en una proliferación linfocitaria que se inicia primariamente en el tracto uveal. Aunque se considera un proceso poco maligno, este caso de diagnóstico tardío demuestra su tendencia a la extensión orbitaria y sistémica (AU)


Asunto(s)
Anciano , Masculino , Humanos , Vincristina , Enucleación del Ojo , Glaucoma Neovascular , Linfoma de Células B , Linfoma no Hodgkin , Enfermedades de la Coroides , Progresión de la Enfermedad , Seudolinfoma , Invasividad Neoplásica , Paraproteínas , Prednisona , Inducción de Remisión , Desprendimiento de Retina , Protocolos de Quimioterapia Combinada Antineoplásica , Ciclofosfamida , Neoplasias Orbitales , Médula Ósea , Neoplasias de la Coroides , Doxorrubicina , Cadenas kappa de Inmunoglobulina , Glaucoma de Ángulo Abierto
16.
Peptides ; 23(9): 1617-23, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12217422

RESUMEN

Mammalian neurokinin A (NKA) and substance P (SP) are neuropeptides widely distributed in the body; they are potential regulators of the basal blood flow and therefore of the function of many organs and tissues. In the present investigation, we studied the age-dependent changes in NKA and SP in ovary, liver, pancreas and spleen as well as the role of exogenous melatonin on these changes. Female rats of 5, 15 or 25 months of age were studied. In the ovary, NKA concentrations did not change during aging. SP concentrations in the control group were significantly higher (P<0.01) in old rats than in the other two age groups studied. Melatonin treatment resulted in reduced concentrations as compared with those of the control old rats. In the pancreas, NKA and SP concentrations increased during aging, the young rats showing significantly lower values (P<0.01) than middle-aged and old rats for NKA and significantly lower (P<0.01) than the old rats for SP. After melatonin treatment the differences in NKA concentrations disappeared and SP decreased in middle-aged as compared with those in old rats. In the liver, NKA and SP concentrations in the control and melatonin-treated groups did not differ significantly for the three age groups studied. Splenic NKA in control and melatonin-treated groups increased from young to middle-age up to old ages. SP concentrations showed similar values at all ages except in melatonin-treated old rats; in these animals there were significantly higher concentrations than in young melatonin-treated rats. The effect of melatonin was mainly observed on the ovary and pancreas in old rats, with a reduction in the concentrations as compared with those observed in the young groups.


Asunto(s)
Envejecimiento , Melatonina/metabolismo , Taquicininas/biosíntesis , Factores de Edad , Animales , Femenino , Hígado/metabolismo , Melatonina/farmacología , Ovario/metabolismo , Péptidos/química , Ratas , Ratas Wistar , Bazo/metabolismo , Factores de Tiempo , Distribución Tisular
17.
Neurologia ; 16(9): 434-8, 2001 Nov.
Artículo en Español | MEDLINE | ID: mdl-11742625

RESUMEN

The acute spinal cord infarction is a rare cause of acute-onset paraplegia. Furthermore, it is specially uncommon that the infarction occurs in patients with apparent low predisposition to vascular disease. The 20210A allele of the prothrombin gene (causing a threefold-increased risk in venous thromboembolism) was recently associated with unexplained spinal cord infarction in young women under treatment with estrogens (contraceptive pill). We report a case of anterior spinal artery syndrome resulting from an ischaemic infarction at the anterior aspect of the spinal cord in a healthy 50-year-old woman, carrying this mutation, being the first published case under treatment with transdermal estradiol. She referred the typical sudden-onset back pain associated to clinical anterior spinal artery syndrome with sphincter dysfunction and nontraumatic paraplegia. A possible multiple sclerosis was ruled out and the steroids or immunoglobulin therapy induced no clinical improvement. Cerebrospinal fluid and other investigations were all negative. Sequential MRI scans revealed development of spinal cord infarction from T10 to T11, with increased signal in T2-weighted image (T2). Because she referred a previous thrombophlebitis and suffered a deep-vein thrombosis one month after paraplegia, a complete coagulation study was performed. Antithrombin, proteins C and S, homocysteine, factor V Leiden, lupus anticoagulant and anticardiolipin antibodies were all normal or negatives. In opposite, the 20210A variation was positive (heterozygous) and the factor VIIIc level was very high (280 U/dl eight months later). We argue the relative importance of both findings. The patient had no a substantial recovery over a period of 20 months.Certainly, the prothrombin 20210A seems to be associated with unexplained ischemic myelopathy among the young women with estrogens.


Asunto(s)
Estrógenos/efectos adversos , Infarto/etiología , Protrombina/genética , Isquemia de la Médula Espinal/etiología , Médula Espinal/irrigación sanguínea , Trombosis de la Vena/etiología , Alelos , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Recurrencia
18.
Acta Neurobiol Exp (Wars) ; 61(1): 27-33, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11315319

RESUMEN

The influence of in vivo melatonin administration on in vitro pituitary follicle stimulating hormone (FSH), growth hormone (GH) and prolactin secretion, as well as the possible influence of dopamine (DA) were evaluated in prepubertal (31-day-old), pubertal (33-day-old) and adult female rats at diestrus phase of the sexual cycle. The in vitro pituitary hormone secretions were evaluated at basal rate for the first hour of incubation only, in Krebs Ringer phosphate (KRP) (I1) and after a second hour of incubation with KRP (I2) or with KRP+DA (I2 plus DA). I1PRL secretion was significantly higher in 33-day-old control and melatonin treated (MEL) rats as compared to I2 periods. However, in 31-day-old rats I1 secretion was higher than in the I2 or I2+DA periods, in MEL rats. In vitro GH secretion was significantly higher at I1 than during I2 periods in the control 31- and 33-day-old groups, but not in MEL rats. The only significant effect of DA was the elevation of GH in prepubertal MEL rats. In vitro FSH release was increased by melatonin in 31- and 33-day-old female rats. No differences in PRL, GH and FSH secretion were found in adult rats. In conclusion, the results show that melatonin effects upon in vitro pituitary gland activity are reproductive-stage-dependent modifying the secretory capacity of the lactotrop, gonadotrop and somatotrop during prepubertal and pubertal ages but not in adult rats studied at a quiescent phase of the sexual cycle.


Asunto(s)
Hormona Folículo Estimulante/metabolismo , Hormona de Crecimiento Humana/metabolismo , Melatonina/farmacología , Prolactina/metabolismo , Maduración Sexual/fisiología , Animales , Dopamina/fisiología , Femenino , Técnicas In Vitro , Ratas , Ratas Wistar , Estimulación Química
19.
Mech Ageing Dev ; 114(3): 173-83, 2000 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-10802121

RESUMEN

The effect of ageing and/or melatonin (MEL) on in vitro gonadotropins, luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (PRL) release and tissue content from pituitary and median eminence (ME) were investigated. Gonadotropins and PRL basal release (I-1) from hemipituitaries of young cyclic-rats was decreased by MEL to levels shown in old acyclic rats. Pituitary tissue content of LH and PRL were not affected by ageing or MEL treatment. However, pituitary FSH tissue content was decreased by ageing and MEL, suggesting a different regulatory mechanism. MEL inhibitory influence on pituitary hormones is mainly exerted on the secretory process. This effect is only exerted in young rats. ME LH and PRL release and content were significantly lower than in pituitary. However, FSH release and content in ME showed values similar to those found in the pituitary. This study confirms that the functional capacities of pituitary gland and ME are maintained during reproductive senescence.


Asunto(s)
Envejecimiento/fisiología , Gonadotropinas/metabolismo , Eminencia Media/metabolismo , Melatonina/metabolismo , Hipófisis/metabolismo , Prolactina/metabolismo , Animales , Femenino , Técnicas In Vitro , Ratas , Ratas Wistar
20.
Med Clin (Barc) ; 114(1): 7-12, 2000 Jan 15.
Artículo en Español | MEDLINE | ID: mdl-10782453

RESUMEN

BACKGROUND: High levels of plasma total homocysteine (tHcy) are involved in arterial or venous occlusive diseases. It essentially depends on the nutritional status of folic acid (FA) and vitamins B12 or B6, but also on the methylenetetrahydrofolate reductase (MTHFR) enzymatic activity. We aim to evaluate the response of the hyperhomocysteinemia (HHcy) to a standard schedule of vitamin supplementation, according with the MTHFR genotype. PATIENTS AND METHODS: 227 patients, diagnosed with venous thromboembolism (VTE) were analysed for tHcy (in fasting conditions), and for the MTHFR-C677T gene polymorphism. When the tHcy exceeded the cut-off point (men = 16, women = 15 mumol/l), the patients were supplemented with a dose equivalent to 1 mg FA, 0.2 mg B12 and 100 mg of B6, daily by 6 weeks. Afterwards they were reanalysed and the reduction was stratified by MTHFR genotype, looking for any difference in the response. RESULTS: The mean fasting tHcy was 12.3 mumol/l (SD = 8). The 51 hyperhomocysteinemic patients (22%) were older (65.1 y) than the normal ones (55.0 y) (p = 0.0001). The treatment was carried out properly in 46 patients (90%). The pre-treatment mean Hcy was 23.2 (SD = 10.5) mumol/l, and it was reduced to 13.0 (SD = 5.9) (p = 0.0001) (mean reduction = 42.1%). By genotype, the C/C reduced from 21.0 to 13.2 mumol/l (37%) (n = 18), the C/T from 25.0 to 12.6 mumol/l (46%) (n = 24), and the abnormal homozygotes T/T from 22.7 to 14.5 mumol/l (39%) (n = 4), although no statistical significant differences were found. In 80% of cases (37/46), tHcy values normalised. A negative correlation (r = -0.471) (p = 0.005) was observed between age and response. CONCLUSIONS: The FA/B6/B12 based therapy reduces in a simple, quick and effective way (> 40% in 6 weeks) the pathologic tHcy levels on a VTE population and this is not influenced by the MTHFR genotype. As HHcy seems related with recurrences of venous thrombosis, we could speculate if it would be useful to analyse routinely the tHcy, attempting reduction in selected cases.


Asunto(s)
Ácido Fólico/farmacología , Ácido Fólico/uso terapéutico , Expresión Génica/genética , Homocisteína/sangre , Homocisteína/metabolismo , Metilenotetrahidrofolato Deshidrogenasa (NADP)/genética , Metilenotetrahidrofolato Deshidrogenasa (NADP)/metabolismo , Piridoxina/farmacología , Piridoxina/uso terapéutico , Tromboflebitis , Vitamina B 12/farmacología , Vitamina B 12/uso terapéutico , Adulto , Electroforesis/métodos , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo Genético/genética , Recurrencia , Tromboflebitis/tratamiento farmacológico , Tromboflebitis/enzimología , Tromboflebitis/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...